After years of debilitating pain, Edward Mowery found hope through a cutting-edge pain management technique that could change lives. Discover how this innovative approach is transforming chronic pain treatment without opioids.
Dr. Sanjay Gupta shares his personal experience with pain and discusses innovative techniques for pain management in his new book. Discover how the brain processes pain and the potential of new treatments!
As the Supreme Court prepares to rule on President Trump's global tariffs, the implications for his economic agenda and executive power are monumental. This decision could reshape international trade and market dynamics.
Nearly 30 years after its film debut, 'The Rainmaker' gets a gripping TV revamp on USA. Follow Rudy Baylor’s tumultuous journey as he battles a hospital over a wrongful death case. Will he emerge victorious or get burned?
U.S. health officials are sounding the alarm about 7-hydroxymitragynine, an opioid ingredient found in energy drinks and gummies. A nationwide ban is being recommended to protect consumers from its dangers.
The Trump administration is delaying and may cancel $140 million in grants crucial for fentanyl overdose response, threatening lives and public health programs nationwide. Experts warn this could lead to catastrophic consequences for addiction care.
President Trump leaves the G7 summit early to address the intensifying Israel-Iran conflict. Panic ensues in Tehran as tensions rise. Meanwhile, Purdue Pharma's $7.4 billion opioid settlement stirs debates.
All 50 states and U.S. territories have approved a monumental $7.4 billion settlement with Purdue Pharma for its role in the opioid crisis. The plan aims to hold the Sackler family accountable while providing funds for communities recovering from addiction.
A pharmacy error nearly led to tragedy for a 9-year-old boy when he was mistakenly given a potent opioid instead of his ADHD medication. His family shares their alarming experience and urges caution.
Overdose deaths in the U.S. fell by nearly 30,000 last year, marking a significant decline in the drug crisis. Experts are cautiously optimistic about the progress, attributing it to improved treatment access and changes in the drug supply.
